Rx Importation Sinks In Senate, But Leaves Anticounterfeiting Regs In Its Wake

Although the drug importation provisions included in the Senate's version of the FDA Revitalization Act are not expected to create a cross-border trading system, their anticounterfeiting language could still have a significant impact on industry